Literature DB >> 23135409

Batch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer.

Artem Lebedev1, Reza Miraghaie, Kishore Kotta, Carroll E Ball, Jianzhong Zhang, Monte S Buchsbaum, Hartmuth C Kolb, Arkadij Elizarov.   

Abstract

The very first microfluidic device used for the production of (18)F-labeled tracers for clinical research is reported along with the first human Positron Emission Tomography scan obtained with a microfluidically produced radiotracer. The system integrates all operations necessary for the transformation of [(18)F]fluoride in irradiated cyclotron target water to a dose of radiopharmaceutical suitable for use in clinical research. The key microfluidic technologies developed for the device are a fluoride concentration system and a microfluidic batch reactor assembly. Concentration of fluoride was achieved by means of absorption of the fluoride anion on a micro ion-exchange column (5 μL of resin) followed by release of the radioactivity with 45 μL of the release solution (95 ± 3% overall efficiency). The reactor assembly includes an injection-molded reactor chip and a transparent machined lid press-fitted together. The resulting 50 μL cavity has a unique shape designed to minimize losses of liquid during reactor filling and liquid evaporation. The cavity has 8 ports for gases and liquids, each equipped with a 2-way on-chip mechanical valve rated for pressure up to 20.68 bar (300 psi). The temperature is controlled by a thermoelectric heater capable of heating the reactor up to 180 °C from RT in 150 s. A camera captures live video of the processes in the reactor. HPLC-based purification and reformulation units are also integrated in the device. The system is based on "split-box architecture", with reagents loaded from outside of the radiation shielding. It can be installed either in a standard hot cell, or as a self-shielded unit. Along with a high level of integration and automation, split-box architecture allowed for multiple production runs without the user being exposed to radiation fields. The system was used to support clinical trials of [(18)F]fallypride, a neuroimaging radiopharmaceutical under IND Application #109,880.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135409      PMCID: PMC3743669          DOI: 10.1039/c2lc40853h

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  28 in total

1.  Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.

Authors:  Jogeshwar Mukherjee; Bradley T Christian; Kelly A Dunigan; Bingzhi Shi; Tanjore K Narayanan; Martin Satter; Joseph Mantil
Journal:  Synapse       Date:  2002-12-01       Impact factor: 2.562

2.  Micro-chemical synthesis of molecular probes on an electronic microfluidic device.

Authors:  Pei Yuin Keng; Supin Chen; Huijiang Ding; Saman Sadeghi; Gaurav J Shah; Alex Dooraghi; Michael E Phelps; Nagichettiar Satyamurthy; Arion F Chatziioannou; Chang-Jin Kim; R Michael van Dam
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-30       Impact factor: 11.205

3.  Improved synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU).

Authors:  Harry Anderson; Nagavarakishore Pillarsetty; Melchor Cantorias; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2010-03-06       Impact factor: 2.408

Review 4.  Synthesis modules and automation in F-18 labeling.

Authors:  R Krasikova
Journal:  Ernst Schering Res Found Workshop       Date:  2007

5.  Fast and repetitive in-capillary production of [18F]FDG.

Authors:  Hans-Jürgen Wester; Bent Wilhelm Schoultz; Christina Hultsch; Gjermund Henriksen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-27       Impact factor: 9.236

Review 6.  PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.

Authors:  Keigo Endo; Noboru Oriuchi; Tetsuya Higuchi; Yasuhiko Iida; Hirofumi Hanaoka; Mitsuyuki Miyakubo; Tomohiro Ishikita; Keiko Koyama
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

7.  PET imaging of hypoxia using [18F]HX4: a phase I trial.

Authors:  Judith van Loon; Marco H M Janssen; Michel Ollers; Hugo J W L Aerts; Ludwig Dubois; Monique Hochstenbag; Anne-Marie C Dingemans; Roy Lalisang; Boudewijn Brans; Bert Windhorst; Guus A van Dongen; Hartmuth Kolb; James Zhang; Dirk De Ruysscher; Philippe Lambin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-06       Impact factor: 9.236

8.  Microfluidic approach for fast labeling optimization and dose-on-demand implementation.

Authors:  Giancarlo Pascali; Grazia Mazzone; Giuseppe Saccomanni; Clementina Manera; Piero A Salvadori
Journal:  Nucl Med Biol       Date:  2010-04-24       Impact factor: 2.408

Review 9.  The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.

Authors:  Tomas de Paulis
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

10.  Flow optimization study of a batch microfluidics PET tracer synthesizing device.

Authors:  Arkadij M Elizarov; Carl Meinhart; Reza Miraghaie; R Michael van Dam; Jiang Huang; Antoine Daridon; James R Heath; Hartmuth C Kolb
Journal:  Biomed Microdevices       Date:  2011-02       Impact factor: 2.838

View more
  17 in total

1.  Microfluidic continuous-flow radiosynthesis of [18F]FPEB suitable for human PET imaging.

Authors:  Steven H Liang; Daniel L Yokell; Raul N Jackson; Peter A Rice; Ronald Callahan; Keith A Johnson; David Alagille; Gilles Tamagnan; Thomas Lee Collier; Neil Vasdev
Journal:  Medchemcomm       Date:  2014-04-01       Impact factor: 3.597

2.  An automated synthesizer for electrochemical 18F-fluorination of organic compounds.

Authors:  Christopher M Waldmann; Artem Lebedev; Nathaniel Allison; Saman Sadeghi
Journal:  Appl Radiat Isot       Date:  2017-06-21       Impact factor: 1.513

3.  Optimization of nucleophilic ¹⁸F radiofluorinations using a microfluidic reaction approach.

Authors:  Giancarlo Pascali; Lidia Matesic; Thomas L Collier; Naomi Wyatt; Benjamin H Fraser; Tien Q Pham; Piero A Salvadori; Ivan Greguric
Journal:  Nat Protoc       Date:  2014-07-31       Impact factor: 13.491

4.  Ultra-compact, automated microdroplet radiosynthesizer.

Authors:  Jia Wang; Philip H Chao; R Michael van Dam
Journal:  Lab Chip       Date:  2019-06-12       Impact factor: 6.799

5.  Titania-catalyzed radiofluorination of tosylated precursors in highly aqueous medium.

Authors:  Maxim E Sergeev; Federica Morgia; Mark Lazari; Christopher Wang; R Michael van Dam
Journal:  J Am Chem Soc       Date:  2015-04-22       Impact factor: 15.419

6.  High yield and high specific activity synthesis of [18F]fallypride in a batch microfluidic reactor for micro-PET imaging.

Authors:  Muhammad Rashed Javed; Supin Chen; Jack Lei; Jeffrey Collins; Maxim Sergeev; Hee-Kwon Kim; Chang-Jin Kim; R Michael van Dam; Pei Yuin Keng
Journal:  Chem Commun (Camb)       Date:  2014-02-07       Impact factor: 6.222

7.  Digital Microfluidics: A New Paradigm for Radiochemistry.

Authors:  Pei Yuin Keng; R Michael van Dam
Journal:  Mol Imaging       Date:  2015-12-05       Impact factor: 4.488

8.  Efficient radiosynthesis of 3'-deoxy-3'-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip.

Authors:  Muhammad Rashed Javed; Supin Chen; Hee-Kwon Kim; Liu Wei; Johannes Czernin; Chang-Jin C J Kim; R Michael van Dam; Pei Yuin Keng
Journal:  J Nucl Med       Date:  2013-12-23       Impact factor: 10.057

9.  Synthesis of 18F-Arenes from Spirocyclic Iodonium(III) Ylides via Continuous-Flow Microfluidics.

Authors:  Samuel Calderwood; Thomas Lee Collier; Véronique Gouverneur; Steven H Liang; Neil Vasdev
Journal:  J Fluor Chem       Date:  2015-08-12       Impact factor: 2.050

Review 10.  The Current Role of Microfluidics in Radiofluorination Chemistry.

Authors:  Karla-Anne Knapp; Michael L Nickels; H Charles Manning
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.